EXPANSION OF IDUSTRIAL BASE FOR BIOLOGICAL VACCINE PRODUCTIO

File: 110596_sep96_decls8_0001.txt
Page: 0001
Total Pages: 2

Subject: EXPANSION OF IDUSTRIAL BASE FOR BIOLOGICAL VACCINE PRODUCTIO    

Unit: OTSG        

Parent Organization: HSC         

Box ID: BX003202

Folder Title: EXPANSION OF INDUSTRIAL BASE FOR BIOLOGICAL VACCINE                                             

Document Number:          1

Folder SEQ  #:          2


                                  c%rop[T UNCLASSIFIED
                                  -Uygur

                         THE ASSISTANT SECRETARY OF DEFENSE

                               WASHINGTON, D. C. 20301-1200

                                                                      NOV in

   HEALTH AFFAIRS





       MEMORANDUM FOR SECRETARY OF THE ARMY

       SUBJECT: Expansion of Industrial Base for Biological Vaccine
                 Production

                                                                           C:)
                                                                           In
                On October 3, 1990, the Secretary of Defense directed
                                                                           Ln
       that I take the necessary actions, on a priority basis, to       ,ci
       acquire second sources to produce biological vaccines to prozecz
       against anthrax and botulinum toxin (Enclosure 1). To accompiisr"   C:)
       this in an accelerated timeframe, on October 5, 1990, I charterecu  a)
       a Tri-Service Task Force to develop short-term options and
       recommendations for increasing vaccine production (Enclosure 2).

                Enclosure 3 is a copy of the Tri-Service Task Force's
       report on the Short Term Production of Anthrax Vaccine.
       Enclosure 4 is a copy of the Tri-Service Task Force's report on
       Short Term Production of BotUlinum Toxoid.                          In

                Currently, the Army has a contract with the Michigan
       Dep     nt of Public Health in Lansing, Michigan, to produce
       anthrax vaccine and another contract with them to blend available-,-,
       botulinuiu toxoid serotypes into pentavalent botulinum toxoid




                After carefully reviewing both of the reports, I request
       that you take the necessary steps, on a priority basis, to carry
       out the following actions:

                 1. Closely monitor the ongoing efforts to increase the
ion capability of the current contractor, Michigan
       Department of Public Health in Lansing, Michigan. Provide any
       support that may be necessary to ensure that production is
       increased by February 20, 1991.


       Classified by Multiple Sources
       Declassify on OADR

       DECLASSIFIED
       ON: 29 OCT 96
       BY: SEC ARMY (DAMH) UNDER SEC 3.4 EO 12958
            lo                           r"7T. UNCLASSIFIE@,,,
    Fl LE

Document 2 f:/Week-36/BX003202/EXPANSION OF INDUSTRIAL BASE FOR BIOLOGICAL VACCINE/expansion of idustrial base for biological vacci:1104960910109
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003202
Unit = OTSG
Parent Organization = HSC
Folder Title = EXPANSION OF INDUSTRIAL BASE FOR BIOLOGICAL VACCINE
Folder Seq # = 2
Subject = EXPANSION OF IDUSTRIAL BASE FOR BIOLOGICAL VACCI
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 04-NOV-1996